SHORT ORAL PRESENTATION 3 - 4I 1
Tracks
SOFIA
| Wednesday, October 22, 2025 |
| 2:00 PM - 3:30 PM |
Details
Sofia Room
Moderators: Carlo Pietrasanta, Italy and Johan Gyllensvärd, Sweden
348
B-Cell Levels, Humoral Responses and 1-Year Follow-Up in Infants Potentially Exposed to Ocrelizumab During Pregnancy: The Prospective, Multicentre, Open-Label, Phase IV MINORE Study
Carlo Pietrasanta, Italy
277
Neonatal Late-Onset Sepsis Recovery Score: development and validation of a clinical cure score for neonates with late-onset sepsis
Zoë Vander Elst, Belgium
343
The Relevance of Central Line Tip Cultures in Neonatal Sepsis: Reviewing Local Practice. Is It Time for a Change?
Ebehireme Ann Edeko, United Kingdom
213
Reevaluating universal antibiotic use in neonates undergoing therapeutic hypothermia: insights from a multicenter study in Italy and Belgium
Domenico Umberto De Rose, Italy
228
RETHINKING ROUTINE PROPHYLAXIS: IS EUROPE OVERUSING ANTIBIOTICS FOR OPHTHALMIA NEONATORUM?
Cinzia Auriti, Italy
661
Dissecting immune cell phenotype and function in CMV-infected newborns through single-cell sequencing
Carlo Pietrasanta, Italy
757
The Diagnostic Gap: CMV Identification Through Clinical Signs Alone
Emre Dincer, Turkey
423
Optimal Diagnostic Cut-Offs and Predictive Markers for Culture-Positive Neonatal Sepsis at a Tertiary Hospital in Ethiopia.
Merhawit Hagos, Ethiopia
179
Evaluation of Hemostatic Parameters and Concentrations of Interleukin-6 (IL-6) and Interferon-γ–Inducible Chemokine IP-10 in Neonates of Mothers Infected with COVID-19 During the Perinatal Period
Alexandra Lianou, Greece
130
Correlation between neurodevelopemental outcomes and brain MRI severity score in patients with congenital cytomegalovirus infection: a monocentric restrospective study
Alessia Spadavecchia, Italy
285
Unveiling The Power of Platelet-To-Lymphocyte Ratio as a Game-Changer in Late-Onset Neonatal Sepsis Diagnosis
Melda Tas, Türkiye
204
The Impact of Histologic Chorioamnionitis on Mortality and Morbidity in Preterm Infants
Sinem Gülcan Kersin, Türkiye
437
Postnatally acquired cytomegalovirus in extremely preterm born infants: an observational cohort study
Sara Krøis Holm, Denmark
288
Bloody Stool in the Newborn: Harmless Symptom or Indicator of Severe Disease?
Özge Aydemir, Türkiye
795
Gloves and gowns in the NICU: is it worth the effort? Results of the BALTIC Study (Barrier protection to lower transmission and infection rates with Gram-negative bacteria in preterm children)
Kirstin Barbara Faust, Germany
770
Probiotic use in extremely preterm infants – a Norwegian population-based study from 2014-2021
Nina Hapnes, Norway
538
Variations in antibiotic use for culture-negative sepsis in late preterm and full-term newborns: A nationwide population-based cohort
Johan Gyllensvärd, Sweden
536
Neonatal sepsis caused by coagulase-negative staphylococci: To treat or not to treat
Frida Oldendorff, Sweden
Moderators: Carlo Pietrasanta, Italy and Johan Gyllensvärd, Sweden
348
B-Cell Levels, Humoral Responses and 1-Year Follow-Up in Infants Potentially Exposed to Ocrelizumab During Pregnancy: The Prospective, Multicentre, Open-Label, Phase IV MINORE Study
Carlo Pietrasanta, Italy
277
Neonatal Late-Onset Sepsis Recovery Score: development and validation of a clinical cure score for neonates with late-onset sepsis
Zoë Vander Elst, Belgium
343
The Relevance of Central Line Tip Cultures in Neonatal Sepsis: Reviewing Local Practice. Is It Time for a Change?
Ebehireme Ann Edeko, United Kingdom
213
Reevaluating universal antibiotic use in neonates undergoing therapeutic hypothermia: insights from a multicenter study in Italy and Belgium
Domenico Umberto De Rose, Italy
228
RETHINKING ROUTINE PROPHYLAXIS: IS EUROPE OVERUSING ANTIBIOTICS FOR OPHTHALMIA NEONATORUM?
Cinzia Auriti, Italy
661
Dissecting immune cell phenotype and function in CMV-infected newborns through single-cell sequencing
Carlo Pietrasanta, Italy
757
The Diagnostic Gap: CMV Identification Through Clinical Signs Alone
Emre Dincer, Turkey
423
Optimal Diagnostic Cut-Offs and Predictive Markers for Culture-Positive Neonatal Sepsis at a Tertiary Hospital in Ethiopia.
Merhawit Hagos, Ethiopia
179
Evaluation of Hemostatic Parameters and Concentrations of Interleukin-6 (IL-6) and Interferon-γ–Inducible Chemokine IP-10 in Neonates of Mothers Infected with COVID-19 During the Perinatal Period
Alexandra Lianou, Greece
130
Correlation between neurodevelopemental outcomes and brain MRI severity score in patients with congenital cytomegalovirus infection: a monocentric restrospective study
Alessia Spadavecchia, Italy
285
Unveiling The Power of Platelet-To-Lymphocyte Ratio as a Game-Changer in Late-Onset Neonatal Sepsis Diagnosis
Melda Tas, Türkiye
204
The Impact of Histologic Chorioamnionitis on Mortality and Morbidity in Preterm Infants
Sinem Gülcan Kersin, Türkiye
437
Postnatally acquired cytomegalovirus in extremely preterm born infants: an observational cohort study
Sara Krøis Holm, Denmark
288
Bloody Stool in the Newborn: Harmless Symptom or Indicator of Severe Disease?
Özge Aydemir, Türkiye
795
Gloves and gowns in the NICU: is it worth the effort? Results of the BALTIC Study (Barrier protection to lower transmission and infection rates with Gram-negative bacteria in preterm children)
Kirstin Barbara Faust, Germany
770
Probiotic use in extremely preterm infants – a Norwegian population-based study from 2014-2021
Nina Hapnes, Norway
538
Variations in antibiotic use for culture-negative sepsis in late preterm and full-term newborns: A nationwide population-based cohort
Johan Gyllensvärd, Sweden
536
Neonatal sepsis caused by coagulase-negative staphylococci: To treat or not to treat
Frida Oldendorff, Sweden
Speaker
Prof. Cinzia Auriti
Doctor
Unicamillus University Of Rome
RETHINKING ROUTINE PROPHYLAXIS: IS EUROPE OVERUSING ANTIBIOTICS FOR OPHTHALMIA NEONATORUM?
Prof. Özge Aydemir
Physician
Eskisehir Osmangazi University Faculty Of Medicine
Bloody Stool in the Newborn: Harmless Symptom or Indicator of Severe Disease?
Dr. Domenico Umberto De Rose
Physician
"bambino Gesù" Children's Hospital Irccs
Reevaluating universal antibiotic use in neonates undergoing therapeutic hypothermia: insights from a multicenter study in Italy and Belgium
Dr. Emre Dincer
Physician
Zeynep Kamil.maternity And Childrens Disease Hospital
The Diagnostic Gap: CMV Identification Through Clinical Signs Alone
Dr. Ebehireme Ann Edeko
Resident
Luton & Dunstable University Hospital Nhs Trust
The Relevance of Central Line Tip Cultures in Neonatal Sepsis: Reviewing Local Practice. Is It Time for a Change?
Dr. Kirstin Barbara Faust
Physician
Department of pediatrics, University of Lübeck
Gloves and gowns in the NICU: is it worth the effort? Results of the BALTIC Study (Barrier protection to lower transmission and infection rates with Gram-negative bacteria in preterm children)
Dr. Sinem Gülcan Kersin
Doctor
Marmara University Pendik Training And Research Hospital
The Impact of Histologic Chorioamnionitis on Mortality and Morbidity in Preterm Infants
Mr. Johan Gyllensvärd
Physician
Ryhov County Hospital
Variations in antibiotic use for culture-negative sepsis in late preterm and full-term newborns: A nationwide population-based cohort
Dr. Merhawit Hagos
Physician
Saint Paul's Hospital Millennium Medical College
Optimal Diagnostic Cut-Offs and Predictive Markers for Culture-Positive Neonatal Sepsis at a Tertiary Hospital in Ethiopia.
Dr. Nina Hapnes
Doctor
Stavanger University Hospital
Probiotic use in extremely preterm infants – a Norwegian population-based study from 2014-2021
Dr. Sara Krøis Holm
Physician
University Hospital Copenhagen Rigshospitalet
Postnatally acquired cytomegalovirus in extremely preterm born infants: an observational cohort study
Dr. Alexandra Lianou
Resident
National and Kapodistrian University Of Athens, Greece
Evaluation of Hemostatic Parameters and Concentrations of Interleukin-6 (IL-6) and Interferon-γ–Inducible Chemokine IP-10 in Neonates of Mothers Infected with COVID-19 During the Perinatal Period
Mrs. Frida Oldendorff
Doctor
Karolinska Institutet
Neonatal sepsis caused by coagulase-negative staphylococci: To treat or not to treat
Dr. Carlo Pietrasanta
Researcher
Department of Clinical Sciences and Community Health, University of Milan
B-Cell Levels, Humoral Responses and 1-Year Follow-Up in Infants Potentially Exposed to Ocrelizumab During Pregnancy: The Prospective, Multicentre, Open-Label, Phase IV MINORE Study
Dr. Carlo Pietrasanta
Researcher
Department of Clinical Sciences and Community Health, University of Milan
Dissecting immune cell phenotype and function in CMV-infected newborns through single-cell sequencing
Dr. Alessia Spadavecchia
Resident
Neonatal Intensive Care Unit Of The University, Città Della Salute E Della Scienza
Correlation between neurodevelopemental outcomes and brain MRI severity score in patients with congenital cytomegalovirus infection: a monocentric restrospective study
Dr. Melda Tas
Physician
Ankara Training And Research Hospital
Unveiling The Power of Platelet-To-Lymphocyte Ratio as a Game-Changer in Late-Onset Neonatal Sepsis Diagnosis
Dr. Zoe Vander Elst
Resident
UZ Leuven/KU Leuven
Neonatal Late-Onset Sepsis Recovery Score: development and validation of a clinical cure score for neonates with late-onset sepsis
The Organising Secretariat
Any questions or comments please contact us at info@jenscongress.eu
Follow us to stay updated!
